Abstract
Growth hormone therapy after myocardial infarction improves cardiac function and survival in animals. Beneficial effects in humans are reported from studies where patients with idiopathic dilated cardiomyopathy were treated with growth hormone. We have studied the role of the endogenous growth hormone system in myocardial infarction.
Original language | English |
---|---|
Journal | European Heart Journal |
Volume | 21 |
Issue number | 18 |
Pages (from-to) | 1547-54 |
Number of pages | 8 |
ISSN | 0195-668X |
DOIs | |
Publication status | Published - Sept 2000 |
Keywords
- Aged
- Biological Markers
- C-Reactive Protein
- Chi-Square Distribution
- Echocardiography
- Female
- Human Growth Hormone
- Humans
- Hydrocortisone
- Insulin-Like Growth Factor I
- Male
- Middle Aged
- Myocardial Infarction
- Radioimmunoassay
- Statistics, Nonparametric
- Ventricular Dysfunction, Left